Ironwood Pharmaceuticals (IRWD) EPS (Basic) Growth (3y) (2013 - 2026)
Ironwood Pharmaceuticals (IRWD) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 678.17 Mn | 599.04 Mn | - | 26.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.92% |
| Mar 31, 2026 | -5.54% |
| Dec 31, 2025 | -47.85% |
| Sep 30, 2025 | -9.08% |
| Jun 30, 2025 | -15.50% |
| Mar 31, 2025 | -43.33% |
| Dec 31, 2024 | 56.25% |
| Sep 30, 2024 | -59.39% |
| Jun 30, 2024 | -26.04% |
| Mar 31, 2024 | -28.18% |
| Dec 31, 2023 | -74.08% |
| Jun 30, 2023 | -26.92% |
| Mar 31, 2023 | -75.89% |
| Mar 31, 2022 | 26.01% |
| Dec 31, 2021 | 53.70% |
| Sep 30, 2021 | 26.04% |
| Jun 30, 2021 | 26.30% |
| Mar 31, 2021 | 26.04% |
| Dec 31, 2020 | -22.10% |
| Jun 30, 2020 | 35.26% |